Purpose: To investigate the natural history of dot subretinal drusenoid deposits (SDD) in age-related macular degeneration, using high-resolution adaptive optics scanning laser ophthalmoscopy.
S
ubretinal drusenoid deposits (SDD) are extracellular lesions found between the photoreceptors and retinal pigment epithelium layer. 1, 2 These lesions clinically manifest as pseudodrusen, 2-4 an entity first described by Mimoun et al 5 as a distinctive yellowish pattern "visible en lumière bleue" (visible in blue light) in many eyes with age-related macular degeneration (AMD). Pseudodrusen are highly associated with progression to neovascularization 6 and geographic atrophy, [7] [8] [9] [10] [11] [12] two late stages of AMD. Recently, Spaide 13 described outer retinal atrophy, a severe photoreceptor degeneration in eyes with regressed SDD, suggested that this entity was a third form of late AMD. Compared with drusen, the hallmark extracellular lesion of AMD, SDD accumulate in a distinct layer of the outer retina, 2, 3, 14 appear with different retinal topography, 3, 15 and have similar proteins but different cholesterol forms. 1, 16 The biogenesis and pathogenic significance of SDD in AMD pathophysiology are currently under intensive study by numerous investigators. Furthermore, it is reasonable to expect that changes in the overall SDD population will be correlated to visual function of an eye with SDD.
Determining why and how SDD are linked to late stage AMD and how they affect vision would be assisted by an accurate natural history. Subretinal drusenoid deposit progression has been assessed at the eye level using standard clinical imaging modalities, [9] [10] [11] [17] [18] [19] [20] including infrared scanning laser ophthalmoscopy (SLO), autofluorescence, and spectral domain optical coherence tomography (SD-OCT). With SD-OCT, individual SDD lesions were classified into three stages by Zweifel et al. 3 Querques et al 17 suggested a fourth stage, of regression. There are challenges to assessing SDD regression accurately. It is difficult to precisely align OCT at the same location of the same lesion across different imaging sessions. 19 Subretinal drusenoid deposit regression may involve several steps that are not currently defined. Since the original description of stages in SD-OCT, 3 SDD morphologies of dot, ribbon (or reticular), and confluent have been clearly demonstrated in en face imaging. [21] [22] [23] These forms appear to have their own progression sequences, with dot proceeding preferentially to neovascularization and confluent proceeding preferentially to geographic atrophy. 22 Precise observation of individual SDD may be informative about how these population changes arise.
Previously, we demonstrated that adaptive optics scanning laser ophthalmoscopy (AOSLO) can disclose SDD microstructure with unprecedented resolution and fidelity. 24, 25 The purpose of this study was to assess SDD dynamism at the level of individual dot lesions using AOSLO over a 12-month period. Conducting invivo microscopy of SDD progression in this manner will allow us to answer important questions: do dot SDD progress directly along Stages 1-2-3? Do lesions disappear? By studying every dot SDD within a region of interest (ROI), we can precisely assess their impact on the overlying neurosensory retina during different phases of the lesion lifecycle.
Methods
The study followed the tenets of the Declaration of Helsinki, complied with the Health Insurance Portability and Accountability Act of 1996, and was approved by the Institutional Review Board at the University of Alabama at Birmingham. Written informed consent was obtained from participants after the nature and possible consequences of the study were explained.
Patients
Study patients were a subgroup from an earlier study of SDD microstructure. 25 Patients previously diagnosed with AMD were recruited from the clinical research registry of the Department of Ophthalmology of the University of Alabama at Birmingham and through the Retina Service. The presence and severity of AMD were determined by masked grading of fundus photographs using the Age-Related Eye Disease Study (AREDS) severity scale. 26 Stereoscopic color digital 30°fundus photographs were taken with an FF450 Plus fundus camera (Carl Zeiss Meditec, Dublin, CA) after pupil dilation. Disease severity ranged from early to intermediate (AREDS . Exclusion criteria at enrollment were diabetes, history of retinal vascular occlusions, and any signs or history of hereditary retinal dystrophy. If patients developed any of the following conditions after enrollment, they were also excluded from the analyses reported here: neovascularization or any other retinal disease in the study eye such as retinal vascular (diabetic retinopathy, retinal vein occlusion) or vitreoretinal (vitreomacular traction syndrome, epiretinal membrane) disease. Subjects were also excluded for reasons that might potentially prevent successful imaging, such as poor fixation, significant media opacity, irregular pupil shape, poor dilation, or refractive error beyond ±6 D spherical and ±3 D cylinder. All participants underwent best-corrected visual acuity measurement by the Electronic Visual Acuity protocol. 27 
Timeline and Study Protocol
Baseline imaging was performed between February 2012 and January 2013. Follow-up imaging using the same procedures was performed between April 2013 and August 2013. Imaging procedures were detailed previously 25 and are briefly summarized here. Because of some patients moving away from the area and development of other conditions (e.g., neovascularization), only some patients studied at baseline returned for follow-up study.
High-Resolution Adaptive Optics Scanning Laser Ophthalmoscopy Image Acquisition and Process
The AOSLO is a new generation research system equipped with a custom high-speed Shack-Hartmann wavefront sensor and a high-speed deformable mirror (Hi-Speed DM97-15; ALPAO SAS, MontbonnotSaint-Martin, France) with 97 actuators with stroke up to 30 mm that provide improved correction ability for 24, 25, 28, 29 It uses a low coherence light source (Broadlighter S840-HP; Diodes Ltd., Cork, Ireland) to mitigate light interference artifact thereby producing high-fidelity retinal images. 30 The AOSLO acquires retinal images with a field of view of 1.2°· 1.2°inside the eye at a frame rate of 15 Hz. Before imaging, pupils were dilated with 1.0% tropicamide and 2.5% phenylephrine hydrochloride. Adaptive optics scanning laser ophthalmoscopy videos were recorded continuously across an area approximately 20°· 20°. Registered images were averaged to enhance signal-tonoise ratio. Images of different retinal locations were manually aligned on a cell-to-cell basis to create a montage using professional image processing software (Photoshop; Adobe Systems Inc, Mountain View, CA). Adaptive optics scanning laser ophthalmoscopy image pixel size was computed from an image of a precisely calibrated dot grid placed at the retinal plane of a model eye.
Multimodal Imaging and Registration
Color fundus photographs, en face near-infrared reflectance (l = 830 nm), red-free (l = 560 nm), and autofluorescence (excitation, 488 nm; emission . 600 nm) images were acquired with the confocal SLO of the Spectralis (Heidelberg Engineering, Carlsbad, CA). All images were acquired with a 30°field of view. Retinal cross-sections were imaged with the Spectralis SD-OCT (l = 870 nm; scan depth, 1.9 mm; axial resolution, 3.5 mm per pixel in tissue; lateral resolution, 14 mm per pixel in tissue). In each study eye, 97 B-scans were acquired across a 15°· 10°area of the central macula to create a volume at the baseline study. At follow-up, the scan volume was extended to 194 B-scans across the central 20°· 20°macula. We use nomenclature of Staurenghi et al 31 for SD-OCT bands. Color fundus photographs and en face near-infrared reflectance, redfree, and autofluorescence images were registered manually by use of retinal vessels and capillaries as fiduciary landmarks. Color fundus photographs and SLO nearinfrared reflectance images were then magnified and registered with the AOSLO montage by use of retinal vessels and capillaries as landmarks. For Figures 1-3 , alternate labeling schemes not using color are available as Supplemental Digital Content 1 (see Figures 1-3 , http://links.lww.com/IAE/A600; http://links.lww.com/ IAE/A601; http://links.lww.com/IAE/A602).
Subretinal Drusenoid Deposit Identification and Classification
Subretinal drusenoid deposits identified by presence in at least two en face imaging modalities and in SD-OCT at baseline were also examined at follow-up.
Each lesion was scored with the three-stage grading system of Zweifel et al. 3 In all patients, both dot and "ribbon" SDD were discerned, and for analysis, we chose to follow the progression of "dots" for comparability with previous studies 17, 19, 33 and also because our imaging instrument did not reveal ribbon SDD distinctly.
Quantifying Subretinal Drusenoid Deposit-Affected Area in the Central 30°of the Macula Imaged by Adaptive Optics Scanning Laser Ophthalmoscopy and Near-Infrared Reflectance At baseline and follow-up, multiple ROIs containing SDD representing local lesion distribution were selected in AOSLO images. In each ROI, the hyporeflective area of the retina associated with each individual SDD 25 was delineated manually using the Polygon Selections tool and summed using the "Analyze Particles" tool of ImageJ (version 1.50a; http:// rsbweb.nih.gov/ij/; National Institutes of Health, Bethesda, MD). For Stage 1 and 2 lesions, the affected retinal area was hyporeflective. For Stage 3 lesions, the affected area included a hyporeflective annulus plus the hyperreflective SDD in the center.
Because most dot SDD are conical, en face crosssectional areas of individual lesions could vary with the level of AOSLO focus. Therefore, SDD areas were measured only at a focal plane where surrounding cone inner segments were apparent (see Figure 1 , CD, Supplemental Digital Content 1, http://links.lww.com/ IAE/A600). Because AOSLO has axial resolution of 70 mm, images are formed by aggregate light reflected from a volume of dimensions 2.8 mm · 2.8 mm · 70 mm (the lateral resolution of AOSLO is 2.8 mm). When defocus in either direction from the plane of best photoreceptor visibility exceeds axial resolution, cells are not visible (see Figure 1 , AB and EF, Supplemental Digital Content 1, http://links.lww.com/IAE/A600).
In focused images, we measured the following:
1. Sizes of individual SDD-affected retinal areas are reported in units of equivalent diameter d i (micrometer), which were calculated by d i ¼ 2 ffiffiffiffiffiffiffiffiffi s i =p p , where s i is the retinal area affected by an individual lesion, and p is the constant ratio of a circle's circumference to its diameter. To assist manual delineation, the borders of hyporeflective retina associated with each individual SDD were identified and enhanced in two standardized steps (Photoshop; Adobe Systems Inc). The image was first filtered (Filter . Blur . Gaussian Blur, "Radius" = 3 pixels), then sharpened (Filter . Sharpen . Smart Sharpen, "Amount" = 180%, "Radius" = 64 pixels). Parameter settings were determined by two experienced observers (authors Y.Z. and X.W.) in preliminary studies. Adaptive optics scanning laser ophthalmoscopy disclosed the dynamism of SDD progression and regression (Figure 1 ). Lesions can appear (green arrows), expand (yellow arrows), shrink (red arrowheads), and disappear (yellow and magenta arrowheads). Corresponding changes are also visible in cross-sectional SD-OCT. Figure 2 shows that individual lesions at the same stage are distinct enough to be readily followed. Figure 3 demonstrates a monotonic progression from Stage 2 to 3 via 2 different B scans through each lesion. It also confirms how the size of individual lesions revealed by SD-OCT is highly dependent on the position of the scan, as previously stated. 19 A total of 269 solitary SDD identified at baseline were also seen at follow-up (Figure 4 ). Of these, 35 15 as will be described in a separate report. 32 The subject is an 84-year-old (at the baseline study) woman (white non-Hispanic) with nonneovascular AMD (Age-Related Eye Disease Study Grade 7, bestcorrected visual acuity 20/20). An alternate labeling scheme not using color is available as Supplemental Digital Content 2 (see Figure 2, 6 were associated with focal hyperreflectivity in the outer nuclear layer, as described by Querques et al. 17 To contextualize this intraretinal hyperreflectivity, we randomly chose 50 Stage 3 SDD that did not disappear and found that 15 of these lesions also were associated with focal hyperreflectivity. Finally, 12 newly developed SDD were identified, of which 6 (50%) were Stage 1, 2 (16.7%) were Stage 2, and 4 (33.3%) were Stage 3.
Mean equivalent diameters of SDD-affected retinal areas at baseline and follow-up (Table 1) increased over the follow-up period. Mean values tend to mask time-dependent changes of individual lesions, and it was noted that lesions remaining at the same stage could still change size. For 12 SDD remaining at Stage 2, 9 (75%) enlarged, and 3 (25%) shrank. For 191 SDD remaining at Stage 3, 139 (73%) enlarged, and 52 (27%) shrank. Figure 5 , top row, shows that in 5/6 eyes, the mean percentage of ROI affected by SDD increased (range, baseline to follow-up: 7.5%-9.0%, a 20.0% increase; 14.4%-20.7%, a 43.8% increase). In one eye, the percentage of ROI affected by SDD decreased slightly (10.7%-10.5%). Figure 5 , bottom row, accordingly shows that in 5/6 eyes, lesion burden over the central 30°increased (range, baseline to follow-up: ). An alternate labeling scheme not using color is available as Supplemental Digital Content 3 (see Figure 3 , http://links.lww.com/ IAE/A602). ELM, external limiting membrane; RPE-BrM, retinal pigment epithelium-Bruch membrane.
5.24-6.72 mm 2 , a 28.3% increase; 0.36-1.45 mm 2 , a 306.8% increase). In one eye, lesion burden decreased 1% (7.88-7.80 mm 2 ). In 5 eyes, the retinal area containing SDD extended beyond the 30°imaged by near-infrared reflectance. Thus, lesion burden assessed within the central 30°is an underestimate of the true burden. Table 2 shows for each eye the percentage of ROI affected by SDD that were stable, new, or regressed, and the results for absolute net change are consistent with Figure 5 . Dynamism is a measure of overall disease activity, defined as the sum of areas affected by new and regressed lesions, ranged from 0.7% in Eye 2 to 9.3% in Eye 1. Eye 4 had a slight net loss over the observation period, yet had nearly equal growth and regression.
Discussion
In this study, we demonstrated the progression of individual SDD over a period of approximately 12 months using high-resolution AOSLO. Subretinal An alternate labeling scheme not using color is available as Supplemental Digital Content 4 (see Figure 4 , http://links.lww. com/IAE/A603). ELM, external limiting membrane; RPE-BrM, retinal pigment epitheliumBruch membrane. drusenoid deposits progressed from early to advanced stages, and no SDD at Stage 1 or 2 at baseline disappeared, supporting an evolution implied by the Zweifel 3-stage system. 3 We confirmed that some Stage 3 SDD indeed disappeared, as suggested by Querques et al 17 who observed in 48 patients followed 24 months a fading of subretinal material accompanied by ellipsoid zone disruption and loss. Longitudinal follow-up of individual lesions over time indicates that SDD are dynamic, as are drusen. If populations of SDD regress, with loss of architecture of the superjacent retina, the net result is outer retinal atrophy. 13 Our evidence for SDD disappearance is strong because for each individual lesion seen in AOSLO, the subretinal location and stage was corroborated in SD-OCT. Our findings are not necessarily inconsistent with those of Steinberg et al, 19 who did not observe SDD disappearance in 18 eyes of 12 patients in shorter periods (2-10 months), even with dense SD-OCT volumes scan (11 mm spacing). Steinberg et al suggested that misaligned B-scans across imaging sessions could cause a false impression of lesion disappearance if they transected edges rather than centers of lesions at followup, which we demonstrate here in correlated AOSLO and SD-OCT (Figure 3) . Pixel-to-pixel correlation in the Spectralis OCT-SLO is now known to have a colocalization error of 42.2 ± 32.4 mm 35 due to optical resolution (14 mm lateral), image digitization (pixel size: 6-11 mm/pixel), image signal-to-noise ratio, and within-frame image distortion 36 introduced by eye movement. 37 Adaptive optics scanning laser ophthalmoscopy provides lateral resolution of 2.8 mm which is 1/10th of the diameter of the smallest SDD detected. 25 Using photoreceptor mosaic as an en face reference (see Figure 1 , Supplemental Digital Content 1, http://links.lww.com/IAE/A600), we could observe stage-specific structure and dimension of individual lesions 25 over time more accurately than had we used B-scan alignment alone. Thus, even with a followup period not that much longer than Steinberg et al, 19 we were able to confirm SDD disappearance. 17 A concept learned from drusen and applicable to SDD is that extracellular lesions are dynamic with stages of development, progression, and regression, involving participation of neighboring cells. Drusen undergo growth followed by collapse, as described in histopathology 38, 39 and recently quantified with OCT technologies, some automated. [40] [41] [42] [43] [44] One model of druse growth involves retention of retinal pigment epithelium-secreted material including lipoproteins by aging Bruch membrane. 45 The cells and secreted factors (e.g., metalloproteinases, lipases) responsible for druse removal are not established. Macrophages are widely believed to clear drusen, 39 ,46 yet direct evidence on this point is scant. However, Müller cell gliosis is prominent in atrophic areas, 47, 48 and processes of presumed Müller cells appear to break up basal laminar deposit persisting after the death of overlying retinal pigment epithelium. 49 Furthermore, microglia invade the outer retina in areas of photoreceptor loss 50, 51 and in eyes with drusen cleared by experimental nanosecond laser treatment. 52 Subretinal drusenoid deposit dynamism is a balance of production and clearance of molecules secreted by neighboring cells involved in lipid recycling, 2 retinoid processing, 21 4 These observations are consistent with removal of SDD material by cells in the retina; whether this material is also associated with hyperreflectivity is currently unknown. Our current data cannot address whether reflective material in the outer nuclear layer is SDD and whether it is specifically associated with lesion disappearance. Data from more lesions at a longer follow-up, ideally with histopathologic correlation, are required to determine the nature of this material. Previous measures of SDD load in individual eyes included the area affected and number of lesions. 19, 33 In our limited sample of eyes, as much as 20% of any 1 retinal location could be affected, and this percentage could go up or down in follow-up. As reported for drusen, 34 an eye could exhibit little net change yet have simultaneous growth and regression suggesting very active disease (Eye 4 in Table 2 ). Subretinal drusenoid deposits' subretinal location suggests a direct effect on surrounding photoreceptors in addition to impaired transport to and from the choroid. 2 In SDD-bearing areas of eyes with intermediate AMD, photopic and mesopic sensitivities are reduced, as tested by microperimetry. [53] [54] [55] [56] Furthermore, dark adaptation is so impaired in such eyes 54 that involvement of Initial and final are the percentages of the ROI affected by SDD at baseline and follow-up. All numbers are percentage area of ROI in some eyes, multiple ROIs were combined.
Abs Net, absolute net change, or Final -Initial; Dynamism, New + Resorbed; New, SDD present only at Follow-up; Resorbed, SDD present at baseline but not at follow-up; Stable, SDD present at both baseline and follow-up. a widespread retinal or retinal pigment epithelium dysfunction beyond the directly affected photoreceptors is highly likely. Visual sensitivity is very poor when SDD involute and the outer retina collapse. Our SDD metrics may thus have their greatest value in assessing the functional impact of SDD in early AMD; more research on this point is needed.
Previously used in clinical trials for counting cone photoreceptors, 57 AOSLO was used, herein, to measure percentage of the outer retina affected by SDD and the burden and dynamism of lesions in the aggregate. These measures may be used as clinical endpoints for evaluating agents designed to reduce SDD, when these become available. Because we could characterize SDD progression and regression at the level of individual lesions within a period of just over a year, use of AOSLO could effectively shorten the length and reduce the cost of proof-of-concept clinical trials, as suggested for measuring aggregate druse volume. 58 A strength of our study is the stage determination by both en face and cross-sectional imaging for each of many individual SDD lesions. Limitations are the short follow-up period, the small number of eyes, and the attention to dot lesions over other SDD subtypes. Although the percentage of the retina affected by individual SDD was assessed in multiple ROIs, AOSLO images were acquired within the central 20°, so we likely underestimated lesion load. Potential bias in the selection of AOSLO ROIs can be reduced in future studies using systematic sampling. Our ongoing and future studies involve a longer follow-up assessment of photoreceptor status, including use of directional OCT 59 and development of software for automated calculation of SDD burden. Nevertheless, current data motivate histologic studies of SDD clearance as well as in vivo studies designed to derive a quantitative relationship between lesion burden and photoreceptor function, especially in early AMD. In conclusion, we improved our knowledge of the SDD dynamism with multimodal high-resolution imaging and deepened our understanding of SDD's role in AMD pathobiology.
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